Skip to content

Assembly Biosciences ASMB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Efficiency
Asset turnover0.4×0.0×0.4×+0.2×0.2×-0.1×0.3×0.0×0.3×+0.1×
Liquidity
Current ratio6.6×+1.4×5.2×+0.8×4.4×+2.8×1.6×-0.4×-0.4×
Quick ratio6.6×+1.4×5.2×+0.8×4.4×+2.8×1.6×-0.4×-0.4×
Cash ratio0.9×-0.3×1.2×+0.8×0.4×-0.1×0.5×0.0×0.5×-0.3×
Leverage
Debt-to-equity0.0×0.0×-0.1×0.2×0.0×0.1×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$11.75-36.3%$18.44+28.1%$14.40+509%$2.36-34.6%$3.61-34.9%
Valuation
Market capitalization$480.77M+262%$537.94M+174%$196.41M+49.5%$131.37M+83.1%$71.73M-28.5%
Enterprise value$452.14M+302%$482.12M+173%$176.63M+60.2%$110.24M+115%$51.34M-21.1%
Price / sales6.8×+2.6×7.4×+2.2×5.3×+1.3×+1.7×2.2×-1.3×
Price / book2.4×-2.5×2.6×+1.5×1.1×-6.2×7.3×+4.6×2.6×-0.4×
EV / sales6.4×+2.9×6.7×+1.9×4.7×+1.4×3.3×+1.7×1.6×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Assembly Biosciences's ratios come from?
Every ratio is computed from Assembly Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.